TME Pharma N.V. Total Liabilities

Latest as of December 2025: €3.72 Million EUR ≈ $4.35 Million USD

TME Pharma N.V. total liabilities. Based on the latest financial reports, TME Pharma N.V. (ALTME) has total liabilities worth €3.72 Million EUR (≈ $4.35 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check TME Pharma N.V. liquidity resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of TME Pharma N.V. (2014–2025)

Total liabilities of TME Pharma N.V. from 2014 to 2025. This chart illustrates how TME Pharma N.V.'s total liabilities have evolved over time, based on quarterly financial data. Explore ALTME long-term investment intensity to see how much of total assets are deployed in long-term investments.

TME Pharma N.V. Competitors by Total Liabilities

The table below lists competitors of TME Pharma N.V. ranked by their total liabilities.

Company	Country	Total Liabilities
Jinzhou Port Co Ltd B SHG:900952	China	$9.91 Billion
Hudson Investment Group Ltd AU:HGL	Australia	AU$12.57 Million
FingerMotion Inc NASDAQ:FNGR	USA	$48.57 Million
GLG Corp Ltd AU:GLE	Australia	AU$35.21 Million
Great Northern Minerals Ltd AU:GNM	Australia	AU$139.85K
Mount Burgess Mining NL AU:MTB	Australia	AU$5.17 Million
Johan Holdings Bhd KLSE:3441	Malaysia	RM153.54 Million
Quoin Pharmaceuticals Ltd DRC NASDAQ:QNRX	USA	$8.04 Million

Liability Composition Analysis (2014–2025)

This chart breaks down TME Pharma N.V.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see TME Pharma N.V. total assets.

Liquidity & Leverage Metrics

TME Pharma N.V. Total Liabilities Ratios Explained

TME Pharma N.V. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	0.57	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-2.35	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.74	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how TME Pharma N.V.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for TME Pharma N.V. (2014–2025)

The table below shows the annual total liabilities of TME Pharma N.V. from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	€3.72 Million ≈ $4.35 Million	+107.48%
2024-12-31	€1.79 Million ≈ $2.10 Million	-35.66%
2023-12-31	€2.79 Million ≈ $3.26 Million	-57.24%
2022-12-31	€6.51 Million ≈ $7.61 Million	+23.68%
2021-12-31	€5.27 Million ≈ $6.16 Million	+78.15%
2020-12-31	€2.96 Million ≈ $3.46 Million	-17.57%
2019-12-31	€3.59 Million ≈ $4.19 Million	-49.67%
2018-12-31	€7.12 Million ≈ $8.33 Million	+46.97%
2017-12-31	€4.85 Million ≈ $5.67 Million	-9.40%
2016-12-31	€5.35 Million ≈ $6.26 Million	-59.07%
2015-12-31	€13.07 Million ≈ $15.28 Million	+40.07%
2014-12-31	€9.33 Million ≈ $10.91 Million	--

About TME Pharma N.V.

PA:ALTME France Biotechnology

Market Cap

$11.79 Million

€10.09 Million EUR

Market Cap Rank

#27652 Global

#483 in France

Share Price

€0.11

Change (1 day)

-4.29%

52-Week Range

€0.05 - €0.16

All Time High

€1994.22